Catalyst Pharmaceuticals Inc Stock Performance
as on May 18, 2026 at 2:16 pm IST
Day's Low
$31.13$31.18
0.16%
Downside
52 Week's Low
52 Week's High
$19.05$32.5638.90%
Downside
4.43%
Upside
Catalyst Pharmaceuticals Inc share price movements today
- Previous Close
- $31.16
- Open
- $31.16
- Volume
- 1.9M
- Day's Low - High
- $31.13 - $31.18
- 52 Week Low - High
- $19.05 - $32.56
Catalyst Pharmaceuticals Inc Historical Returns
- 1 Month Return
- + 20.43 %
- 3 Month Return
- + 28.15 %
- 1 Year Return
- + 27.94 %
- 3 Year Return
- + 149.24 %
- 5 Year Return
- + 465.88 %
Catalyst Pharmaceuticals Inc Stock Fundamentals & Key Indicators
Check Catalyst Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.8B
EPS (TTM)
2.8591
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.11%
PE Ratio (TTM)
18.01
Industry PE ratio
-11.2365625
PEG Ratio
0EBITDA
305.8M
Revenue (TTM)
597.0M
Profit Margin
37.08%
Return On Equity TTM
24.50%
Catalyst Pharmaceuticals Inc Stock Valuation
Track how Catalyst Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Catalyst Pharmaceuticals Inc in the last 5 years
Lowest (10.36x)
March 31, 2026
Industry (-11.24x)
May 16, 2026
Today (18.01x)
May 16, 2026
Highest (28.83x)
June 30, 2024
Today’s Price to Earnings Ratio: 18.01x
Catalyst Pharmaceuticals Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Catalyst Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.8B | 465.88% | 18.01 | 37.08% | |
| BUY | $31.8B | 355.33% | NA | 0.00% | |
| BUY | $39.2B | 111.48% | 73.55 | 12.55% | |
| BUY | $115.0B | 101.28% | 26.89 | 35.51% | |
| BUY | $74.7B | 35.16% | 17.39 | 29.65% |
Stock Returns calculator for Catalyst Pharmaceuticals Inc Stock including INR - Dollar returns
The Catalyst Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Catalyst Pharmaceuticals Inc investment value today
Current value as on today
₹1,44,344
Returns
₹44,344
(+44.34%)
Returns from Catalyst Pharmaceuticals Inc Stock
₹27,944 (+27.94%)
Dollar Impact
₹16,399 (+16.4%)
Analyst Recommendation on Catalyst Pharmaceuticals Inc Stock
Based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Catalyst Pharmaceuticals Inc. Average target price of $33.3
Catalyst Pharmaceuticals Inc Share Price Target
Get share price movements and forecasts by analysts on Catalyst Pharmaceuticals Inc.
What analysts predicted
6.37%UPSIDE
Target Price
$33.3
Current Price
$31.18
Analyzed by
13 Analysts
Target
$33.30
Catalyst Pharmaceuticals Inc target price $33.3, a slight upside of 6.37% compared to current price of $31.18. According to 13 analysts rating.
Indian Investors' Interest in Catalyst Pharmaceuticals Inc Stock
Search interest for Catalyst Pharmaceuticals Inc Stock has increased by 253% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:253% versus previous 30 day period
Catalyst Pharmaceuticals Inc Quarterly Profit & Loss
All numbers in Millions USD
Catalyst Pharmaceuticals Inc Annual Profit & Loss
All numbers in Millions USD
Catalyst Pharmaceuticals Inc Quarterly Cash Flow
All numbers in Millions USD
Catalyst Pharmaceuticals Inc Annual Cash Flow
All numbers in Millions USD
Catalyst Pharmaceuticals Inc News & Key Events
Today's Timeline - 25 March
Wed, 05:53 PM
-Catalyst Pharmaceuticals' 2026 EPS estimates rise from $2.55 to $2.87; Zacks Rank #1 (Strong Buy).
Insights on Catalyst Pharmaceuticals Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 52.69M → 63.73M (in $), with an average increase of 17.3% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, CPRX stock has moved up by 18.7%
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 473.9% return, outperforming this stock by 318.3%
- NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 268.4% return, outperforming this stock by 240.5%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 152.61M → 149.39M (in $), with an average decrease of 2.1% per quarter
About Catalyst Pharmaceuticals Inc
| Organisation | Catalyst Pharmaceuticals Inc |
| Headquarters | 355 Alhambra Circle, Coral Gables, FL, United States, 33134 |
| Industry | Biotechnology |
| CEO | Mr. Richard John Daly M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Catalyst Pharmaceuticals Inc
Name | Title |
|---|---|
Mr. Jeffrey Del Carmen | Executive VP & Chief Commercial Officer |
Ms. Mary Coleman | VP & Head of Investor Relations |
Mr. Brian Elsbernd J.D. | Chief Compliance Officer & Chief Legal Officer |
Mr. Gregg Russo | Chief Human Resources Officer |
Mr. Paul Friel | Executive Vice President of Corporate Operations |
Mr. Michael W. Kalb CPA | Executive VP, Treasurer & CFO |
Dr. Steven R. Miller Ph.D. | Executive VP, COO & Chief Scientific Officer |
Ms. Angie Bechan | Executive VP & Chief Corporate Affairs Officer |
Mr. Patrick J. McEnany | Co-Founder & Non-Executive Chairman |
Mr. Richard John Daly M.B.A. | President, CEO & Director |
FAQs
What is Catalyst Pharmaceuticals Inc share price today?
Catalyst Pharmaceuticals Inc share price today is $31.18 as on at the close of the market. Catalyst Pharmaceuticals Inc share today touched a day high of $31.18 and a low of $31.13.
What is the 52 week high and 52 week low for Catalyst Pharmaceuticals Inc share?
Catalyst Pharmaceuticals Inc share touched a 52 week high of $32.56 on and a 52 week low of $19.05 on . Catalyst Pharmaceuticals Inc stock price today i.e. is closed at $31.18,which is 4.24% down from its 52 week high and 63.67% up from its 52 week low.
What is Catalyst Pharmaceuticals Inc's market capitalisation today?
Catalyst Pharmaceuticals Inc market capitalisation is $0.00T as on .
How to invest in Catalyst Pharmaceuticals Inc Stock (CPRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Catalyst Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Catalyst Pharmaceuticals Inc Shares that will get you 0.0481 shares as per Catalyst Pharmaceuticals Inc share price of $31.18 per share as on May 18, 2026 at 8:46 am IST.
What is the minimum amount required to buy Catalyst Pharmaceuticals Inc Stock (CPRX) from India?
Indian investors can start investing in Catalyst Pharmaceuticals Inc (CPRX) shares with as little as ₹96.335 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.35 in Catalyst Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Catalyst Pharmaceuticals Inc share’s latest price of $31.18 as on May 18, 2026 at 8:46 am IST, you will get 0.3207 shares of Catalyst Pharmaceuticals Inc. Learn more about
fractional shares .
What are the returns that Catalyst Pharmaceuticals Inc has given to Indian investors in the last 5 years?
Catalyst Pharmaceuticals Inc stock has given 465.88% share price returns and 30.59% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?